Several current partially successful approaches for cancer therapy are in agreement with the i-CSC/p-ESC model, targeting crucial factors common to embryos and tumors, such as HSP70, HLA-G, ID, LIF/LIFr, and CD44. This evidence concerns the gene LIF and cancer.